RxDoctor Payments Data

Donna Westermann

Acute Care · Fishersville, VANPI 1174663272

Payments from drug & device makers

$302in general payments, 2019–2025

Across 15 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$68
  • Gilead$34
  • AstraZeneca$32
  • Pharmacyclics LLC, An Abbvie Company$30
  • Regeneron Healthcare Solutions, Inc.$28
  • Pfizer$22
  • plus $88 from 5 others

What the payments were for

  • Food & beverage$29196%
  • Education$124%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$302 in reported general payments places this provider in the 50th percentile of 599 acute care providers in Virginia.

See all acute care providers in Virginia

Medicare billing

Part B allowed, 2024
$2,484
Medicare patients
40
Services billed
42

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamoxifen Citrate23$737
Anastrozole27$273

Paid to pharmacies, not to this prescriber.

Other acute care in Fishersville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →